These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19056247)

  • 1. Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.
    Nozaki S; Kato M; Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Fujimura Y; Matsumoto R; Ota M; Takano A; Otsuka A; Yasuno F; Okubo Y; Kashima H; Suhara T
    Schizophr Res; 2009 Mar; 108(1-3):78-84. PubMed ID: 19056247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[beta-11C]DOPA.
    Ito H; Ota M; Ikoma Y; Seki C; Yasuno F; Takano A; Maeda J; Nakao R; Suzuki K; Suhara T
    Nucl Med Commun; 2006 Sep; 27(9):723-31. PubMed ID: 16894327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
    Lindström LH; Gefvert O; Hagberg G; Lundberg T; Bergström M; Hartvig P; Långström B
    Biol Psychiatry; 1999 Sep; 46(5):681-8. PubMed ID: 10472420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
    Karlsson P; Farde L; Halldin C; Sedvall G
    Am J Psychiatry; 2002 May; 159(5):761-7. PubMed ID: 11986129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with L-[beta-11C]DOPA.
    Ota M; Yasuno F; Ito H; Seki C; Nozaki S; Asada T; Suhara T
    Life Sci; 2006 Jul; 79(8):730-6. PubMed ID: 16580023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
    Talvik M; Nordström AL; Olsson H; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):361-70. PubMed ID: 14604451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of central dopamine synthesis in man, using positron emission tomography with L-[beta-11C]DOPA.
    Ito H; Shidahara M; Takano H; Takahashi H; Nozaki S; Suhara T
    Ann Nucl Med; 2007 Aug; 21(6):355-60. PubMed ID: 17705016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.
    Gründer G; Vernaleken I; Müller MJ; Davids E; Heydari N; Buchholz HG; Bartenstein P; Munk OL; Stoeter P; Wong DF; Gjedde A; Cumming P
    Neuropsychopharmacology; 2003 Apr; 28(4):787-94. PubMed ID: 12655326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter.
    Arakawa R; Ichimiya T; Ito H; Takano A; Okumura M; Takahashi H; Takano H; Yasuno F; Kato M; Okubo Y; Suhara T
    J Psychiatr Res; 2009 Oct; 43(15):1219-23. PubMed ID: 19457493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
    Yasuno F; Suhara T; Okubo Y; Sudo Y; Inoue M; Ichimiya T; Takano A; Nakayama K; Halldin C; Farde L
    Am J Psychiatry; 2004 Jun; 161(6):1016-22. PubMed ID: 15169689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
    Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
    JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.
    Potkin SG; Alva G; Fleming K; Anand R; Keator D; Carreon D; Doo M; Jin Y; Wu JC; Fallon JH
    Am J Psychiatry; 2002 Feb; 159(2):227-37. PubMed ID: 11823264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
    Buchsbaum MS; Christian BT; Lehrer DS; Narayanan TK; Shi B; Mantil J; Kemether E; Oakes TR; Mukherjee J
    Schizophr Res; 2006 Jul; 85(1-3):232-44. PubMed ID: 16713185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
    Siessmeier T; Kienast T; Wrase J; Larsen JL; Braus DF; Smolka MN; Buchholz HG; Schreckenberger M; Rösch F; Cumming P; Mann K; Bartenstein P; Heinz A
    Eur J Neurosci; 2006 Jul; 24(1):305-13. PubMed ID: 16882026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presynaptic dopaminergic function in the striatum of schizophrenic patients.
    Dao-Castellana MH; Paillère-Martinot ML; Hantraye P; Attar-Lévy D; Rémy P; Crouzel C; Artiges E; Féline A; Syrota A; Martinot JL
    Schizophr Res; 1997 Feb; 23(2):167-74. PubMed ID: 9061812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
    Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
    Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.